EP3678649
Nefholsadrenalínsamsetningar og aðferðir til að meðhöndla sjúkdóm
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.2.2019EP published:
26.10.2022EP application number:
19751807.9
EP translation filed:
9.1.2023Grant published:
15.2.2023EPO information:
European Patent Register
Max expiry date:
5.2.2039Expiry date:
5.2.2027Next due date:
28.2.2027
Title in English:
INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASELanguage of the patent:
English
Timeline
Today
6.2.2019EP application
26.10.2022EP Publication
9.1.2023Translation submitted
15.2.2023Registration published
5.2.2027Expires
Owner
Name:
Aegis Therapeutics, LLCAddress:
3430 Carmel Mountain Road, Suite 300, San Diego CA 92121, US
Name:
ARS Pharmaceuticals Operations, Inc.Address:
11682 EL Camino Real, Suite 120, San Diego, California 92130, US
Inventor
Name:
LOWENTHAL, RichardAddress:
San Diego, California 92127, US
Name:
MAGGIO, Edward T.Address:
San Diego, California 92121, US
Name:
BELL, Robert G.Address:
San Diego, California 92127, US
Name:
SHAH, PratikAddress:
San Diego, California 92127, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201815890131Date:
6.2.2018Country:
US
Number:
201862784057 PDate:
21.12.2018Country:
US
Number:
201862685049 PDate:
14.6.2018Country:
US
Number:
201862734550 PDate:
21.9.2018Country:
US
Supplementary protection
SPC number:
SPC500
Classification
Categories:
A61K 31/137, A61K 9/08, A61K 47/26, A61P 27/14
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 19.12.2022
Expires: 5.2.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 18.1.2024
Expires: 5.2.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 20.1.2025
Expires: 5.2.2026
Payer: Árnason Faktor ehf.
Number: 8
Paid: 30.1.2026
Expires: 5.2.2027
Payer: Árnason Faktor ehf.